In case you missed it: Feb. 15 to Feb. 19


It was a very busy week for the Contemporary OB/GYN team.

This week’s top articles included:

Black women scheduling a uterine-sparing treatment for leiomyomas

Black women are more likely to undergo uterine fibroid (UF) treatments that are uterine-sparing compared with their White counterparts, according to a prospective cohort study in the Journal of Women’s Health.

Improving fertility rates and symptoms for peritoneal endometriosis

“We need to find a good balance between conservative and surgical treatment,” said principal investigator Sylvia Mechsner, MD.

Poll: How are ob/gyns feeling about COVID vaccine uptake?

Take a poll and see how other ob/gyns are feeling about patient uptake of the COVID vaccine.

Attendance at an initial LARC follow-up visit

A retrospective chart review has concluded that less than one-third of adolescents and young adults (AYAs) attended an initial follow-up visit after long-acting reversible contraception (LARC) insertion.

Sexual function of breast cancer survivors with GMS after laser treatment

The study provides preliminary evidence of improvements in sexual function in breast cancer survivors who receive laser therapy.

Related Videos
One year out: Fezolinetant displays patient satisfaction for managing hot flashes | Image Credit:
Addressing maternal health inequities: Insights from CDC's Wanda Barfield | Image Credit:
Addressing racial and ethnic disparities in brachial plexus birth Injury | Image Credit:
Innovations in prenatal care: Insights from ACOG 2024 | Image Credit:
Unlocking therapeutic strategies for menopausal cognitive decline | Image Credit:
Navigating menopause care: Expert insights from ACOG 2024 | Image Credit:
raanan meyer, md
New data shows elinzanetant's efficacy in treating menopausal symptoms | Image Credit:
Related Content
© 2024 MJH Life Sciences

All rights reserved.